3billion Company Description

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment.

It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers.

The company was founded in 2016 and is based in Seoul, South Korea.

3billion, Inc.

Country	South Korea
Founded	2016
Industry	In Vitro and In Vivo Diagnostic Substances
CEO	Changwon Keum

Contact Details

Address: 416 Teheran-ro Seoul, 06193 South Korea
Website	3billion.io

Stock Details

Ticker Symbol	394800
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835

Key Executives

Name	Position
Changwon Keum	Chief Executive Officer